# Trade Mark Journal No.2026/009 27 February 2026

## UK00004338055 9 February 2026 (5,42)

Class 5
  Pharmaceutical preparations; therapeutic and prophylactic preparations for the treatment, prevention or management of blood clots, thrombosis, coagulation disorders and cardiovascular condition; anti-fibrinolytic pharmaceutical preparations; small molecule anti fibrinolytic agents for medical use; biopharmaceutical preparations; medicinal preparations containing biological materials; anti thrombotic agents; anticoagulant and antiplatelet preparations; diagnostic preparations for medical purposes; drug delivery agents comprising compounds that facilitate delivery of pharmaceutical preparations; medical and veterinary preparations; dietetic preparations and substances for medical use.
Class 42
  Medical and pharmaceutical research and development; scientific and technological services in the field of thrombosis, coagulation disorders, cardiovascular health and therapeutic development; medical and pharmaceutical research and development; laboratory research services; clinical research; design and development of medical diagnostic tests, therapeutic platforms and drug delivery systems; biotechnology research; providing scientific information and consultancy relating to pharmaceuticals and therapeutics.

ClotProtect Therapeutics Limited

Representative: HGF Limited